Fact CheckerSign in

NCT07348003Completed

Examining the Effectiveness of Single-Limb Exercise Training for COPD Patients During Exacerbation Periods

Source: ClinicalTrials.gov · Last updated 24 Jul 2026

Brief summary (registry, in English)

Resistance exercise applications during acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) are employed to enhance functional capacity and prevent muscle atrophy by increasing muscle strength. Owing to the limited cardiorespiratory reserve of COPD patients, single-limb exercises are better tolerated compared to traditional bilateral exercises. A study conducted by Vogiatzis et al. (2009) indicated that single-leg exercises require lower ventilation and result in more efficient oxygen consumption than bilateral exercises. This physiological advantage may be effective in reducing muscle weakness by increasing exercise endurance in COPD patients with restricted respiratory capacity. The present study aims to demonstrate that single-limb resistance exercise is an effective rehabilitation method for increasing functional exercise capacity in patients during COPD exacerbations compared to a control group. Furthermore, the therapeutic effects of single-limb resistance exercises on dyspnea perception, fatigue, anxiety, and depression will be established. The study will also show that these exercises are both feasible and safe within rehabilitation protocols during the exacerbation period.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
29 Dec 2025
Start date
2 Jan 2026
Primary completion date
1 May 2026
Lead sponsor
Alper Kemal Gürbüz
Diseases
COPD
NCT number
NCT07348003

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 2 Jan 2026 to the primary completion date, 1 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Heart failure classified as New York Heart Association (NYHA) Class III or IV. Unstable mental status (indicated by a Mini-Mental State Examination (MMSE) score of 24).
  • History of major surgery within the last three months. Presence of malignancies.

Who the study is looking for

  • Hospital admission due to an acute COPD exacerbation.
  • Not currently enrolled in an active pulmonary rehabilitation program.
  • Absence of any additional neurological disorders.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hacettepe University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.